Euclid Advisors’s Merck MRK Stock Holding History

Euclid Advisors’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-111,273	Closed	-$6.12M	–	306
2016 Q2	$6.12M	Buy	111,273 +54,915	+97%	+$2.92M	0.27%	133
2016 Q1	$2.85M	Sell	56,358 -101,119	-64%	-$4.95M	0.11%	243
2015 Q4	$7.94M	Buy	+157,477	New	+$7.94M	0.24%	146
2015 Q3	–	Sell	-238,658	Closed	-$13M	–	365
2015 Q2	$13M	Sell	238,658 -843,109	-78%	-$47.3M	0.26%	131
2015 Q1	$59.3M	Buy	+1,081,767	New	+$61.3M	1.09%	15
2014 Q4	–	Sell	-1,537,437	Closed	-$87M	–	455
2014 Q3	$87M	Buy	1,537,437 +82,834	+6%	+$4.65M	0.62%	26
2014 Q2	$80.3M	Sell	1,454,603 -246,364	-14%	-$13.4M	0.56%	33
2014 Q1	$92.1M	Buy	1,700,967 +472,072	+38%	+$24.4M	0.7%	24
2013 Q4	$58.7M	Sell	1,228,895 -60,155	-5%	-$2.75M	0.49%	38
2013 Q3	$58.6M	Buy	1,289,050 +232,310	+22%	+$10.6M	0.59%	29
2013 Q2	$46.8M	Buy	+1,056,740	New	+$47.2M	0.59%	35

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Euclid Advisors's MRK Position: Q3 2016 in Review

Euclid Advisors sold out of Merck (MRK) in Q3 2016, closing a stake of 111,273 shares — an estimated $6.12M sold.

Euclid Advisors first reported a position in MRK in Q2 2013 and held it in 11 quarters. The position peaked at $92.1M in Q1 2014. 1,815 funds tracked by Wall St. Rank hold MRK as of Q3 2016.

Euclid Advisors reported no remaining Merck position as of Q3 2016 after selling out during the quarter.
Euclid Advisors sold 111,273 Merck shares in Q3 2016, an estimated $6.12M.
Euclid Advisors first reported a position in Merck in Q2 2013 and held it in 11 quarters.
Euclid Advisors's Merck position peaked at $92.1M in Q1 2014.
1,815 funds tracked by Wall St. Rank held Merck as of Q3 2016.

Based on Euclid Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.